Picture of BELLUS Health logo

BLU BELLUS Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

U.S. RESEARCH ROUNDUP- Apple, Bellus Health, Emerson Electric

Sept 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Bellus Health, Emerson Electric and Western Union on
Monday. 
    
    HIGHLIGHTS
     * Apple Inc  AAPL.O : JP Morgan establishes Dec 2020 PT of $265 vs Dec 2019 PT of $243
     * Bellus Health Inc  BLU.O : Jefferies initiates coverage with buy rating and $20 PT
     * Emerson Electric Co  EMR.N : RBC raises to outperform from sector perform
     * Western Union Co  WU.N : JP Morgan raises target price to $23 from $22
        
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order.
    
     * Accenture Plc  ACN.N : Cowen and Company raises target price to $205 from $195
     * Apple Inc  AAPL.O : JP Morgan establishes Dec 2020 PT of $265 vs Dec 2019 PT of $243
     * AT&T Inc  T.N : Evercore ISI raises target price to $40 from $34
     * Bellus Health Inc  BLU.O : Jefferies initiates coverage with buy rating and $20 PT
     * Brookfield Infrastructure Partners LP  BIP.N : CIBC raises target price to $53 from $48
     * CBOE Global Markets Inc  CBOE.N : Jefferies raises target price to $110 from $105
     * Deciphera Pharmaceuticals  DCPH.O : Jefferies initiates with buy rating and $47 PT
     * Edison International  EIX.N : RBC raises target price to $79 from $76
     * Emerson Electric Co  EMR.N : RBC raises price target to $77 from $65
     * Emerson Electric Co  EMR.N : RBC raises to outperform from sector perform
     * Granite Construction Inc  GVA.N : Cowen and Company cuts target price to $50 from $65
     * Seattle Genetics Inc  SGEN.O : SVB Leerink raises target price to $102 from $87
     * Vale SA  VALE.N : Credit Suisse cuts target price to $16 from $18
     * Western Union Co  WU.N : JP Morgan raises target price to $23 from $22
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on BELLUS Health

See all news